Tuesday, 16 August 2022

IDH CEO ups stake in the Company

(Cairo and London) — Dr. Hend El Sherbini, Integrated Diagnostics Holdings’ chief executive officer, has purchased 7.3 million additional shares in the Company. This is in line with her commitment to deliver on the Company’s growth and value creation strategy. The purchases were completed between 1 August and 12 August by Hena Holdings Limited (“Hena Holdings”), the vehicle through which Dr. El Sherbini owns her shares, and were announced on the London Stock Exchange (LSE). Following the transaction, Hena Holdings’ stake in IDH has increased to 26.71% from 25.50%, continuing to represent the single largest interest in the Company.

Tap or click here to read the full announcement in pdf.